HU begins human trial for promising treatment to reverse paralysis and language disorder after stroke
Hiroshima University started the human trial for a promising treatment that offers hope in potentially reversing paralysis and language disorder after moderate to severe stroke using therapeutically superior mesenchymal stem cells (MSCs) derived from the cranial bone.
Source: news-medical.net